Tscan therapeutics establishes facility to manufacture t cell receptor engineered t cell therapies

- completion of facility supports upcoming clinical milestones including expected multiple fourth quarter ind filings - - completion of facility supports upcoming clinical milestones including expected multiple fourth quarter ind filings -

TCRX Ratings Summary

TCRX Quant Ranking